BAYER AG-REG (BAYN.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:BAYN - DE000BAY0017 - Common Stock
36.18 EUR
+0.24 (+0.67%)
We assign a fundamental rating of 3 out of 10 to BAYN. BAYN was compared to 52 industry peers in the Pharmaceuticals industry. Both the profitability and financial health of BAYN have multiple concerns. BAYN is cheap, but on the other hand it scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year BAYN was profitable.
In the past year BAYN had a positive cash flow from operations.
In multiple years BAYN reported negative net income over the last 5 years.
In the past 5 years BAYN always reported a positive cash flow from operatings.
1.2 Ratios
The Return On Assets of BAYN (-0.19%) is worse than 63.46% of its industry peers.
BAYN has a worse Return On Equity (-0.67%) than 63.46% of its industry peers.
BAYN has a worse Return On Invested Capital (1.80%) than 63.46% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for BAYN is significantly below the industry average of 13.72%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.19% | ||
| ROE | -0.67% | ||
| ROIC | 1.8% |
ROA(3y)-0.5%
ROA(5y)-1.93%
ROE(3y)-2.08%
ROE(5y)-7.52%
ROIC(3y)5.51%
ROIC(5y)N/A
1.3 Margins
Looking at the Operating Margin, with a value of 4.20%, BAYN is doing worse than 63.46% of the companies in the same industry.
BAYN's Operating Margin has declined in the last couple of years.
The Gross Margin of BAYN (56.35%) is worse than 67.31% of its industry peers.
In the last couple of years the Gross Margin of BAYN has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.2% | ||
| PM (TTM) | N/A | ||
| GM | 56.35% |
OM growth 3Y-18.1%
OM growth 5Y-4.34%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.21%
GM growth 5Y-1.81%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BAYN is destroying value.
The number of shares outstanding for BAYN remains at a similar level compared to 1 year ago.
The number of shares outstanding for BAYN remains at a similar level compared to 5 years ago.
BAYN has a better debt/assets ratio than last year.
2.2 Solvency
BAYN has an Altman-Z score of 0.95. This is a bad value and indicates that BAYN is not financially healthy and even has some risk of bankruptcy.
BAYN has a worse Altman-Z score (0.95) than 69.23% of its industry peers.
BAYN has a debt to FCF ratio of 10.07. This is a negative value and a sign of low solvency as BAYN would need 10.07 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 10.07, BAYN is doing worse than 65.38% of the companies in the same industry.
A Debt/Equity ratio of 1.11 is on the high side and indicates that BAYN has dependencies on debt financing.
BAYN has a worse Debt to Equity ratio (1.11) than 69.23% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.11 | ||
| Debt/FCF | 10.07 | ||
| Altman-Z | 0.95 |
ROIC/WACC0.28
WACC6.43%
2.3 Liquidity
A Current Ratio of 1.14 indicates that BAYN should not have too much problems paying its short term obligations.
The Current ratio of BAYN (1.14) is worse than 69.23% of its industry peers.
BAYN has a Quick Ratio of 1.14. This is a bad value and indicates that BAYN is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of BAYN (0.71) is worse than 75.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.14 | ||
| Quick Ratio | 0.71 |
3. Growth
3.1 Past
BAYN shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -8.72%.
The Earnings Per Share has been decreasing by -5.27% on average over the past years.
Looking at the last year, BAYN shows a decrease in Revenue. The Revenue has decreased by -1.87% in the last year.
BAYN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.37% yearly.
EPS 1Y (TTM)-8.72%
EPS 3Y-8.12%
EPS 5Y-5.27%
EPS Q2Q%137.5%
Revenue 1Y (TTM)-1.87%
Revenue growth 3Y1.87%
Revenue growth 5Y1.37%
Sales Q2Q%-3.09%
3.2 Future
BAYN is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 3.48% yearly.
BAYN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.44% yearly.
EPS Next Y-5.16%
EPS Next 2Y-1.81%
EPS Next 3Y1.63%
EPS Next 5Y3.48%
Revenue Next Year-1.56%
Revenue Next 2Y-0.38%
Revenue Next 3Y0.49%
Revenue Next 5Y1.44%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 6.78, the valuation of BAYN can be described as very cheap.
BAYN's Price/Earnings ratio is rather cheap when compared to the industry. BAYN is cheaper than 96.15% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.92, BAYN is valued rather cheaply.
With a Price/Forward Earnings ratio of 7.43, the valuation of BAYN can be described as very cheap.
Based on the Price/Forward Earnings ratio, BAYN is valued cheaper than 94.23% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.46. BAYN is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 6.78 | ||
| Fwd PE | 7.43 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BAYN is on the same level as its industry peers.
88.46% of the companies in the same industry are more expensive than BAYN, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 9.03 | ||
| EV/EBITDA | 10.8 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-1.81%
EPS Next 3Y1.63%
5. Dividend
5.1 Amount
With a yearly dividend of 0.31%, BAYN is not a good candidate for dividend investing.
BAYN's Dividend Yield is comparable with the industry average which is at 2.20.
With a Dividend Yield of 0.31, BAYN pays less dividend than the S&P500 average, which is at 2.00.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.31% |
5.2 History
The dividend of BAYN decreases each year by -45.34%.
Dividend Growth(5Y)-45.34%
Div Incr Years0
Div Non Decr Years3
5.3 Sustainability
BAYN has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-65.15%
EPS Next 2Y-1.81%
EPS Next 3Y1.63%
FRA:BAYN (12/29/2025, 1:46:03 PM)
36.18
+0.24 (+0.67%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners48.44%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap35.54B
Revenue(TTM)45.87B
Net Income(TTM)-198.00M
Analysts71.43
Price Target34.35 (-5.06%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.31% |
Yearly Dividend0.13
Dividend Growth(5Y)-45.34%
DP-65.15%
Div Incr Years0
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)58.52%
Min EPS beat(2)45.89%
Max EPS beat(2)71.16%
EPS beat(4)4
Avg EPS beat(4)30.58%
Min EPS beat(4)1.86%
Max EPS beat(4)71.16%
EPS beat(8)7
Avg EPS beat(8)18.15%
EPS beat(12)9
Avg EPS beat(12)7.9%
EPS beat(16)12
Avg EPS beat(16)7.93%
Revenue beat(2)0
Avg Revenue beat(2)-2.53%
Min Revenue beat(2)-2.63%
Max Revenue beat(2)-2.42%
Revenue beat(4)1
Avg Revenue beat(4)-1.06%
Min Revenue beat(4)-2.63%
Max Revenue beat(4)1.79%
Revenue beat(8)2
Avg Revenue beat(8)-1.69%
Revenue beat(12)2
Avg Revenue beat(12)-2.67%
Revenue beat(16)6
Avg Revenue beat(16)-1.42%
PT rev (1m)16.14%
PT rev (3m)18.06%
EPS NQ rev (1m)-25.09%
EPS NQ rev (3m)-37.41%
EPS NY rev (1m)1.43%
EPS NY rev (3m)0.86%
Revenue NQ rev (1m)0.06%
Revenue NQ rev (3m)-2.41%
Revenue NY rev (1m)-0.19%
Revenue NY rev (3m)-0.39%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 6.78 | ||
| Fwd PE | 7.43 | ||
| P/S | 0.77 | ||
| P/FCF | 9.03 | ||
| P/OCF | 5.29 | ||
| P/B | 1.2 | ||
| P/tB | N/A | ||
| EV/EBITDA | 10.8 |
EPS(TTM)5.34
EY14.76%
EPS(NY)4.87
Fwd EY13.46%
FCF(TTM)4.01
FCFY11.07%
OCF(TTM)6.84
OCFY18.91%
SpS46.69
BVpS30.11
TBVpS-18.8
PEG (NY)N/A
PEG (5Y)N/A
Graham Number60.14
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.19% | ||
| ROE | -0.67% | ||
| ROCE | 2.56% | ||
| ROIC | 1.8% | ||
| ROICexc | 2% | ||
| ROICexgc | 6.8% | ||
| OM | 4.2% | ||
| PM (TTM) | N/A | ||
| GM | 56.35% | ||
| FCFM | 8.58% |
ROA(3y)-0.5%
ROA(5y)-1.93%
ROE(3y)-2.08%
ROE(5y)-7.52%
ROIC(3y)5.51%
ROIC(5y)N/A
ROICexc(3y)6.21%
ROICexc(5y)N/A
ROICexgc(3y)25.79%
ROICexgc(5y)N/A
ROCE(3y)7.82%
ROCE(5y)N/A
ROICexgc growth 3Y-23.46%
ROICexgc growth 5Y-1.27%
ROICexc growth 3Y-13.2%
ROICexc growth 5Y2.54%
OM growth 3Y-18.1%
OM growth 5Y-4.34%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.21%
GM growth 5Y-1.81%
F-Score5
Asset Turnover0.44
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.11 | ||
| Debt/FCF | 10.07 | ||
| Debt/EBITDA | 5.32 | ||
| Cap/Depr | 66.1% | ||
| Cap/Sales | 6.08% | ||
| Interest Coverage | 1.09 | ||
| Cash Conversion | 109.39% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.14 | ||
| Quick Ratio | 0.71 | ||
| Altman-Z | 0.95 |
F-Score5
WACC6.43%
ROIC/WACC0.28
Cap/Depr(3y)34.81%
Cap/Depr(5y)41.62%
Cap/Sales(3y)5.85%
Cap/Sales(5y)5.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-8.72%
EPS 3Y-8.12%
EPS 5Y-5.27%
EPS Q2Q%137.5%
EPS Next Y-5.16%
EPS Next 2Y-1.81%
EPS Next 3Y1.63%
EPS Next 5Y3.48%
Revenue 1Y (TTM)-1.87%
Revenue growth 3Y1.87%
Revenue growth 5Y1.37%
Sales Q2Q%-3.09%
Revenue Next Year-1.56%
Revenue Next 2Y-0.38%
Revenue Next 3Y0.49%
Revenue Next 5Y1.44%
EBIT growth 1Y-2.82%
EBIT growth 3Y-16.56%
EBIT growth 5Y-3.03%
EBIT Next Year65.28%
EBIT Next 3Y21.41%
EBIT Next 5Y11.27%
FCF growth 1Y873.08%
FCF growth 3Y22.16%
FCF growth 5Y-3.69%
OCF growth 1Y161.6%
OCF growth 3Y12.83%
OCF growth 5Y-2.09%
BAYER AG-REG / BAYN.DE FAQ
What is the fundamental rating for BAYN stock?
ChartMill assigns a fundamental rating of 3 / 10 to BAYN.DE.
What is the valuation status for BAYN stock?
ChartMill assigns a valuation rating of 7 / 10 to BAYER AG-REG (BAYN.DE). This can be considered as Undervalued.
How profitable is BAYER AG-REG (BAYN.DE) stock?
BAYER AG-REG (BAYN.DE) has a profitability rating of 2 / 10.
Can you provide the expected EPS growth for BAYN stock?
The Earnings per Share (EPS) of BAYER AG-REG (BAYN.DE) is expected to decline by -5.16% in the next year.
Is the dividend of BAYER AG-REG sustainable?
The dividend rating of BAYER AG-REG (BAYN.DE) is 1 / 10 and the dividend payout ratio is -65.15%.